Illumina, Inc. (ILMN) stock
ILMNNasdaqLaboratory Analytical InstrumentsFiscal year ends January 3
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Oct 30, 2026Score 13/3016% above fair value
$207.01−2.54 (-1.21%)
Close on Nov 13, 2026Market cap $31.30BP/E 35.5Yield –
Illumina EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Illumina's EPS for the twelve months ending Sep 27, 2026 was $5.83, up 30.7% year over year. For fiscal 2025 it was $5.45. Over ten years it grew 5.8% a year on average. The highest annual figure on record is $6.74 in fiscal 2019.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | $5.45 | – |
| FY2024 | Dec 29, 2024 | -$7.69 | – |
| FY2023 | Dec 31, 2023 | -$7.34 | – |
| FY2022 | Jan 1, 2023 | -$28.00 | -655.6% |
| FY2021 | Jan 2, 2022 | $5.04 | +13.3% |
| FY2020 | Jan 3, 2021 | $4.45 | -34.0% |
| FY2019 | Dec 29, 2019 | $6.74 | +21.2% |
| FY2018 | Dec 30, 2018 | $5.56 | +13.0% |
| FY2017 | Dec 31, 2017 | $4.92 | +60.3% |
| FY2016 | Jan 1, 2017 | $3.07 | -1.0% |
| FY2015 | Jan 3, 2016 | $3.10 | +30.8% |
| FY2014 | Dec 28, 2014 | $2.37 | +163.3% |
| FY2013 | Dec 29, 2013 | $0.90 | -20.4% |
| FY2012 | Dec 30, 2012 | $1.13 | +82.3% |
| FY2011 | Jan 1, 2012 | $0.62 | -28.7% |
| FY2010 | Jan 2, 2011 | $0.87 | +64.2% |
| FY2009 | Jan 3, 2010 | $0.53 | +76.7% |
| FY2008 | Dec 28, 2008 | $0.30 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 27, 2026 | $1.43 | +45.9% |
| Q2 FY2026 | Jun 28, 2026 | $1.35 | -9.4% |
| Q1 FY2026 | Mar 29, 2026 | $0.87 | +6.1% |
| Q4 FY2025 | Dec 28, 2025 | $2.18 | +86.3% |
| Q3 FY2025 | Sep 28, 2025 | $0.98 | -77.8% |
| Q2 FY2025 | Jun 29, 2025 | $1.49 | – |
| Q1 FY2025 | Mar 30, 2025 | $0.82 | – |
| Q4 FY2024 | Dec 29, 2024 | $1.17 | – |
| Q3 FY2024 | Sep 29, 2024 | $4.42 | – |
| Q2 FY2024 | Jun 30, 2024 | -$12.48 | – |
| Q1 FY2024 | Mar 31, 2024 | -$0.79 | -4050.0% |
| Q4 FY2023 | Dec 31, 2023 | -$1.11 | – |
| Q3 FY2023 | Oct 1, 2023 | -$4.77 | – |
| Q2 FY2023 | Jul 2, 2023 | -$1.48 | – |
| Q1 FY2023 | Apr 2, 2023 | $0.02 | -96.4% |
| Q4 FY2022 | Jan 1, 2023 | -$0.89 | -223.6% |
| Q3 FY2022 | Oct 2, 2022 | -$24.26 | -1266.3% |
| Q2 FY2022 | Jul 3, 2022 | -$3.40 | -369.8% |
| Q1 FY2022 | Apr 3, 2022 | $0.55 | -45.0% |
| Q4 FY2021 | Jan 2, 2022 | $0.72 | -58.6% |
| Q3 FY2021 | Oct 3, 2021 | $2.08 | +71.9% |
| Q2 FY2021 | Jul 4, 2021 | $1.26 | +293.8% |
| Q1 FY2021 | Apr 4, 2021 | $1.00 | -14.5% |
| Q4 FY2020 | Jan 3, 2021 | $1.74 | +8.1% |
| Q3 FY2020 | Sep 27, 2020 | $1.21 | -23.4% |
| Q2 FY2020 | Jun 28, 2020 | $0.32 | -83.9% |
| Q1 FY2020 | Mar 29, 2020 | $1.17 | -25.5% |
| Q4 FY2019 | Dec 29, 2019 | $1.61 | +14.2% |
| Q3 FY2019 | Sep 29, 2019 | $1.58 | +18.8% |
| Q2 FY2019 | Jun 30, 2019 | $1.99 | +41.1% |
| Q1 FY2019 | Mar 31, 2019 | $1.57 | +11.3% |
| Q4 FY2018 | Dec 30, 2018 | $1.41 | +206.5% |
| Q3 FY2018 | Sep 30, 2018 | $1.33 | +19.8% |
| Q2 FY2018 | Jul 1, 2018 | $1.41 | +62.1% |
| Q1 FY2018 | Apr 1, 2018 | $1.41 | -43.1% |
| Q4 FY2017 | Dec 31, 2017 | $0.46 | -45.2% |
| Q3 FY2017 | Oct 1, 2017 | $1.11 | – |
| Q2 FY2017 | Jul 2, 2017 | $0.87 | – |
| Q1 FY2017 | Apr 2, 2017 | $2.48 | – |
| Q4 FY2016 | Jan 1, 2017 | $0.84 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?